AstraZeneca AZN and its Japan-based partner Daiichi Sankyo announced that the European Commission (EC) has approved their ...

AstraZeneca will pay $34 million to resolve a lawsuit that alleged the company used illegal kickbacks to induce providers to ...

Texas Attorney General Ken Paxton announced Monday that his office has reached a settlement with AstraZeneca Pharmaceuticals ...

Texas secures nearly 34 million dollar settlement with AstraZeneca over allegations of illegal kickbacks tied to Medicaid ...

When you have pumped massive investment into Shanghai and more recently Beijing it is not difficult for a company to make a ...

Texas Attorney General Ken Paxton announced Monday that AstraZeneca Pharmaceuticals LP will pay nearly $34 million to resolve ...

AstraZeneca (LSE:AZN) is back in focus after a recent pullback, with the stock down about 5% over the past month and over the ...

AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.

AstraZeneca has partnered with YMCA of the USA (Y-USA) to increase awareness of cancer screening and early detection. Now in ...

AZN shares fell after a camizestrant setback, but blockbuster drugs, oncology growth and a deep pipeline support long-term targets.

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

June 2026Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy Recommendation ...